Literature DB >> 10777144

Enhancement of HIV type 1 antigen-specific CD4+ T cell memory in subjects with chronic HIV type 1 infection receiving an HIV type 1 immunogen.

V C Maino1, M A Suni, S B Wormsley, D J Carlo, M R Wallace, R B Moss.   

Abstract

We examined HIV-1 specific memory helper T immune responses in chronically HIV-infected subjects who received an immune-based therapy (HIV-1 immunogen, Remune). Subjects in this study exhibited significant increases (p < 0.05) in the frequency of helper T memory cells expressing interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) in response to HIV-1 antigens in vitro. The frequencies of HIV-specific memory T cells increased after successive immunizations and exhibited a correlation with the standard tritiated thymidine incorporation lymphocyte proliferation assay (r = 0.72, p < 0.0008). These results support the notion that HIV-specific memory immune responses can be stimulated in subjects with chronic HIV infection. Further investigations are warranted to determine whether the induction of such responses is associated with virologic control.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777144     DOI: 10.1089/088922200308954

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  7 in total

Review 1.  Immunofluorescence analysis of T-cell responses in health and disease.

Authors:  H T Maecker; V C Maino; L J Picker
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

2.  Expression of perforin on HIV-1-specific CD8+ lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogen.

Authors:  R B Moss; W K Giermakowska; M R Wallace; F C Jensen; R Z Maigetter; D J Carlo
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

3.  Therapeutic immunization in HIV infected Ugandans receiving stable antiretroviral treatment: a Phase I safety study.

Authors:  Cissy Kityo; Stephanie Bousheri; Juliette Akao; Francis Ssali; Rose Byaruhanga; Isaac Ssewanyana; Prossy Muloma; Sula Myalo; Rose Magala; Yichen Lu; Peter Mugyenyi; Huyen Cao
Journal:  Vaccine       Date:  2011-01-04       Impact factor: 3.641

4.  CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects.

Authors:  M J Boaz; A Waters; S Murad; P J Easterbrook; E D'Sousa; C van Wheeley; A Vyakarnam
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

5.  HIV infection and aging: enhanced Interferon- and Tumor Necrosis Factor-alpha production by the CD8+ CD28- T subset.

Authors:  E H Eylar; C E Lefranc; Y Yamamura; I Báez; S L Colón-Martinez; N Rodriguez; T B Breithaupt
Journal:  BMC Immunol       Date:  2001-10-08       Impact factor: 3.615

6.  Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides.

Authors:  Holden T Maecker; Jeffrey Hassler; Janice K Payne; Amanda Summers; Karrie Comatas; Manar Ghanayem; Michael A Morse; Timothy M Clay; Herbert K Lyerly; Sonny Bhatia; Smita A Ghanekar; Vernon C Maino; Corazon Delarosa; Mary L Disis
Journal:  BMC Immunol       Date:  2008-03-17       Impact factor: 3.615

7.  Immunotherapy with an HIV-DNA Vaccine in Children and Adults.

Authors:  Paolo Palma; Lindvi Gudmundsdotter; Andrea Finocchi; Lars E Eriksson; Nadia Mora; Veronica Santilli; Angela Aquilani; Emma C Manno; Paola Zangari; Maria Luisa Romiti; Carla Montesano; Alba Grifoni; Andreas Brave; Karl Ljungberg; Pontus Blomberg; Stefania Bernardi; Eric Sandström; Bo Hejdeman; Paolo Rossi; Britta Wahren
Journal:  Vaccines (Basel)       Date:  2014-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.